[HTML][HTML] Comparative effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers for major renal outcomes in patients with …
Background Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor
blockers (ARBs) are considered to have similar renoprotective effects; so far there has been …
blockers (ARBs) are considered to have similar renoprotective effects; so far there has been …
Comparative efficacy of individual renin–angiotensin system inhibitors on major renal outcomes in diabetic kidney disease: a network meta-analysis
J Cai, X Huang, Z Zheng, Q Lin… - Nephrology Dialysis …, 2018 - academic.oup.com
Background Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor
blockers (ARBs) are two drug classes with well-documented renal protective effects …
blockers (ARBs) are two drug classes with well-documented renal protective effects …
[HTML][HTML] Renoprotective effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic patients with proteinuria
FY Hsu, FJ Lin, HT Ou, SH Huang… - Kidney and Blood …, 2017 - karger.com
Background/Aims: Limited evidence exists on the choice of angiotensin-converting enzyme
inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) in diabetic patients with …
inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) in diabetic patients with …
[HTML][HTML] A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse …
LS Wu, SH Chang, GJ Chang, JR Liu, YH Chan… - Cardiovascular …, 2016 - Springer
Background Contemporary guidelines recommend angiotensin-converting-enzyme
inhibitors (ACEi) or angiotensin-receptor blockers (ARB) for hypertensive patients with …
inhibitors (ACEi) or angiotensin-receptor blockers (ARB) for hypertensive patients with …
Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for end-stage renal disease/mortality in type 2 diabetes
HM Campbell, N Khan, DW Raisch, ME Borrego… - Diabetes Research and …, 2013 - Elsevier
Aims To compare angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin
receptor blockers (ARBs) for end-stage renal disease (ESRD) development and all-cause …
receptor blockers (ARBs) for end-stage renal disease (ESRD) development and all-cause …
Effects of renin–angiotensin system blockers on renal and cardiovascular outcomes in patients with diabetic nephropathy: a meta-analysis of randomized controlled …
X Liu, L Ma, Z Li - Journal of Endocrinological Investigation, 2020 - Springer
Purpose This study aimed to evaluate the effect f angiotensin-converting enzyme inhibitors
(ACEI) and angiotensin receptor blockers (ARB) on renal or cardiovascular outcomes in …
(ACEI) and angiotensin receptor blockers (ARB) on renal or cardiovascular outcomes in …
Effects of renin–angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis
PA Sarafidis, PC Stafylas, AI Kanaki… - American journal of …, 2008 - academic.oup.com
Background In contrast to previous studies, recent data questioned the ability of renin–
angiotensin–aldosterone system (RAAS) blockers to delay progression of diabetic …
angiotensin–aldosterone system (RAAS) blockers to delay progression of diabetic …
Protection against death and renal failure by renin-angiotensin system blockers in patients with diabetes and kidney disease
J Shen, YM Huang, XN Song, XZ Hong… - Journal of the Renin …, 2016 - journals.sagepub.com
Introduction: Angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor
blockers (ARBs) are widely used to block the renin-angiotensin system (RAS). Yet it remains …
blockers (ARBs) are widely used to block the renin-angiotensin system (RAS). Yet it remains …
Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review
Objective To evaluate the effects of angiotensin converting enzyme (ACE) inhibitors and
angiotensin II receptor antagonists (AIIRAs) on renal outcomes and all cause mortality in …
angiotensin II receptor antagonists (AIIRAs) on renal outcomes and all cause mortality in …
Effects of ACE inhibitors and angiotensin receptor blockers in normotensive patients with diabetic kidney disease
D He, Y Zhang, W Zhang, Y Xing, Y Guo… - Hormone and …, 2020 - thieme-connect.com
The role of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor
blockers (ARBs) in reducing the progression of albuminuria and risk of cardiovascular …
blockers (ARBs) in reducing the progression of albuminuria and risk of cardiovascular …